UBS Remains a Buy on Novo Nordisk (0QIU)
In a report released today, Jo Walton from UBS maintained a Buy rating on Novo Nordisk (0QIU – Research Report), with a price target of ...
Is Novo Nordisk (NVO) the Best Falling Stock to Invest in Right Now?
We recently published a list of 10 Best Falling Stocks to Invest in Right Now. In this article, we are going to take a look ...
Health Care Roundup: Market Talk
Find insight on Novo Nordisk Foundation, ResMed, Johnson & Johnson, and more in the latest Market Talks covering Health Care.
FY2024 Earnings Forecast for NVO Issued By Cantor Fitzgerald
Equities research analysts at Cantor Fitzgerald decreased their FY2024 earnings per share (EPS) estimates for Novo Nordisk ...
European earnings may keep the mood sweet as tariff fears grow
European shares are trading near their largest discount on record to the S&P 500 index, at a forward price-to-earnings ratio ...
LONDON MARKET CLOSE: FTSE 100 steady but Deepseek sparks US tech rout
The pound was quoted at USD1.2479 late Monday afternoon in London, down from USD1.2490 at the equities close on Friday. The euro stood lower at USD1.0505, against USD1.0510. Against the yen, the ...
Novo Nordisk’s Ozempic Gets FDA Approval as Kidney-Disease Treatment
Ozempic, or semaglutide, can now be used to reduce the risk of worsening kidney disease or kidney failure in adults with type ...